IceCure reports ProSense cryoablation growth in Brazil after FDA nod
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
IceCure Highlights Expanding Commercial Adoption of ProSense⢠Cryoablation in Brazil Following FDA Clearance for Breast Cancer
July 6, 2026 8:11 AM EDTGrowing physician interest and commercial adoption for ProSense in Brazil's expanding interventional oncology markets increased following FDA authorization
Independent study evaluating breast cancer cryoablation in 750 patients across Brazil, led by renowned breast surgeon Dr. Vanessa Sanvido, is underway
Dr. Toulsie Ramtohul of Institut Curie, a ProSense user set to lead a 900-patient breast cancer cryoablation study in... More

